Gordon, K, RB Warren, AB Gottlieb, A Blauvelt, D Thaçi, Y Poulin, M Boehnlein, F Brock, C Arendt, and K Reich. 2020. “Durable Efficacy of Certolizumab Pegol Dosed at 400 Mg Every Two Weeks Over 128 Weeks in Patients With Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2, and CIMPACT)”. SKIN The Journal of Cutaneous Medicine 4 (6):s81. https://doi.org/10.25251/skin.4.supp.81.